KADENSA CAPITAL Ltd Buys Shares of 122,609 Astera Labs, Inc. $ALAB

KADENSA CAPITAL Ltd bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 122,609 shares of the company’s stock, valued at approximately $24,007,000. Astera Labs comprises 2.5% of KADENSA CAPITAL Ltd’s holdings, making the stock its 11th largest holding. KADENSA CAPITAL Ltd owned approximately 0.07% of Astera Labs as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Assetmark Inc. raised its position in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Advisors Asset Management Inc. grew its holdings in Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares during the period. Manchester Capital Management LLC increased its stake in Astera Labs by 141.5% in the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after purchasing an additional 283 shares in the last quarter. Pinpoint Asset Management Singapore Pte. Ltd. bought a new stake in Astera Labs in the third quarter valued at approximately $47,000. Finally, Whittier Trust Co. acquired a new stake in Astera Labs in the third quarter worth $55,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the sale, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. This trade represents a 5.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jitendra Mohan sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the sale, the chief executive officer owned 1,452,739 shares in the company, valued at approximately $179,863,615.59. This trade represents a 6.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 224,292 shares of company stock worth $27,676,069. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Up 0.3%

Astera Labs stock opened at $120.31 on Monday. The company has a 50 day moving average of $147.89 and a 200-day moving average of $168.03. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a market capitalization of $20.48 billion, a PE ratio of 98.61, a price-to-earnings-growth ratio of 2.37 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm’s quarterly revenue was up 91.8% on a year-over-year basis. During the same period last year, the business posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Northland Securities raised their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Citigroup reduced their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Morgan Stanley reissued an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, BNP Paribas Exane assumed coverage on Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating for the company. Fifteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $202.22.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.